CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
about
Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individualsInvestigating the Role of Plasma Glucose Concentration as a Phenotypic Marker for CYP2C9 Genetic Variants, in the Diabetic Population of GujaratImplementing genotype-guided antithrombotic therapy.Prevalence of genetic variants associated with cardiovascular disease risk and drug response in the Southern Indian population of Kerala.Genetic polymorphism of drug refractory epilepsyAnalysis of CYP2C9*2, CYP2C9*3 and VKORC1 -1639 G>A polymorphisms in a population from South-Eastern Europe.A study on the impact of CYP2C19 genotype and platelet reactivity assay on patients undergoing PCIFrequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy.Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized MedicineGenetic variation and haplotype structure of the gene Vitamin K epoxide reductase complex, subunit 1 in the Tamilian population.Cytochrome P450 (CYP2C9*2,*3) & vitamin-K epoxide reductase complex (VKORC1 -1639G<A) gene polymorphisms & their effect on acenocoumarol dose in patients with mechanical heart valve replacement.Evaluation of cytochrome P450 2C9 activity in normal, healthy, adult Western Indian population by both phenotyping and genotyping.Evaluation of CYP2C19, P2Y12, and ABCB1 polymorphisms and phenotypic response to clopidogrel in healthy Indian adultsInter and intra ethnic variation of vitamin K epoxide reductase complex and cytochrome P450 4F2 genetic polymorphisms and their prevalence in South Indian population.Influence of Ethnicity, Age, and Time on Sex Disparities in Long-Term Cause-Specific Mortality After Acute Myocardial Infarction.Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature.Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.Association of polymorphism in cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome.Genetic Polymorphism of Cytochrome p450 (2C9) Enzyme in Iranian Baluch Ethnic GroupCorrelation of CYP2C19 genotype with plasma voriconazole levels: a preliminary retrospective study in Indians.Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR.Frequency of selected single nucleotide polymorphisms influencing the warfarin pharmacogenetics in Slovak population.Association of cytochrome P450 2C9 polymorphism with locally advanced head and neck squamous cell carcinoma and response to concurrent cisplatin-based radical chemoradiationGenetic Polymorphism of Cytochrome p450 (2C19) Enzyme in Iranian Turkman Ethnic Group.The value of combining CYP2C19*2 polymorphism with classic risk factors in prediction of clinical prognosis in acute coronary syndrome patients.CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database.Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population.Genotype-phenotype correlation of cytochrome P450 2C9 polymorphism in Indian National Capital Region.Effect of 36 CYP2C9 variants found in the Chinese population on losartan metabolism in vitro.Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes and phenytoin adverse reactions correlation.Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel.Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms.CYP2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects.Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study.An acenocoumarol dosing algorithm exploiting clinical and genetic factors in South Indian (Dravidian) population.Optimization of warfarin dose by population-specific pharmacogenomic algorithm.Effect of antituberculosis treatment on CYP2C19 enzyme activity in genetically polymorphic South Indian Tamilian population.CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment.
P2860
Q28237144-C3073E6B-D3B9-4C07-941F-C88D55215231Q33555327-47D51EB2-1571-412B-B511-A87403DA4462Q33990428-81A28276-3855-4224-97A6-DE43FAC291D1Q34494596-2159EB7C-D1EC-423C-AA0B-97396DD3B0FDQ35351642-47DD89A6-30D0-4514-B329-721A4BE81133Q35370240-ADF26D51-5E1C-4DFD-85BC-D5176758DF24Q35764145-89534566-85F7-471F-AFD3-5296467131CCQ36018001-80D13700-67DC-40F2-84B5-E37E131CE509Q36580034-98635565-95E2-41FB-95A8-0DB91374BAAEQ36813817-756D73E3-6FCE-45D3-BD87-DC6FA1502E36Q36855608-69BAE7CA-61F4-451E-A072-046ABE63A5FFQ36986803-CD35E22D-19BF-45C8-A386-3CACC6FA68F5Q37167282-A1D2FF60-2617-4F96-81A3-E753652018A4Q37345384-4B247E86-D6BB-4A04-94F8-FB0528C79289Q37434574-75030DA1-0CE7-4E64-8150-1ED748579D70Q37715233-57E3A491-10EE-487E-B4DD-95B779042626Q38104273-A4ED2BE3-8EA8-4210-8C53-D54EAA60DAEEQ38616806-CDF6931C-3E91-49A6-9537-FAB36588B3F1Q39701132-FCBE8D2F-FEF3-418D-A384-EC3FA3735C2FQ41096175-69F1DC8A-77CB-45C2-9B0E-24D3D555D0D8Q41708603-E5CA7B94-94AD-43DE-91DC-BB81E8E391F6Q42701943-BF9F8805-4B19-423D-AFC1-F8A2851CB53BQ42705932-ED1CE0F3-8842-45BC-9FD1-BA629B366A51Q42794014-98608AC4-1051-4F56-ACA7-DB43341E1D8EQ43071574-35A22C7C-3742-4C74-9FD7-E54085FA07A2Q43606515-62779224-F48B-4294-BC10-F0E4789C72B2Q43676146-E738352E-A2BC-4043-AC9A-02A4D4C9F9C2Q44495777-43F91491-BEE5-4B51-BEA2-C12059E4C13DQ45058224-B09B2331-B34F-4FF8-921A-DE4C85C63216Q45213491-D3C868C2-BEAF-48CB-AA23-BD17897C2DD6Q46239544-F0E82C65-3B92-44E6-B45F-C17C40EB2E33Q46766394-B5562D2E-FF5F-41B1-BC29-E6E16DD1DC49Q47232877-C66F61DF-36BE-46F1-AC68-B4F7D6363043Q47402745-0B2AB1F9-AC5B-48B8-A0C6-B17833A478B1Q47961774-8722D47B-0773-4F3C-BAD4-C67D03869407Q48058245-66DEFCD3-34C6-461A-A39A-A4DDF837A5CCQ50993101-43475E13-08A9-4C3A-AA45-37D1731ACB53Q51598231-262BA430-0039-44D3-9443-7512953AC038Q51653421-57ED4465-AB7A-402F-A5C9-419408C97280Q55017266-5C2547E9-BB86-416A-9BD1-3ABBE3CE4EC1
P2860
CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
@en
CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
@nl
type
label
CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
@en
CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
@nl
prefLabel
CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
@en
CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
@nl
P2093
P2860
P1476
CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
@en
P2093
Adithan Chandrasekaran
Anitha Peter
Benny K Abraham
K Satyanarayanamoorthy
Krishnamoorthy Rajagopal
Nathalie Gerard
Rosemary Jose
Shashindran Chanolean
Soya Sisy Sam
P2860
P304
P356
10.1111/J.1472-8206.2004.00307.X
P577
2005-02-01T00:00:00Z